NCT05381402

Brief Summary

The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis patients. This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian psoriasis patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
230

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

21 days

First QC Date

May 18, 2022

Last Update Submit

May 18, 2022

Conditions

The Impact of COVID19 on Psoriasis Patients

Outcome Measures

Primary Outcomes (1)

  • Questionnaire

    To assess the effect of COVID 19 on psoriasis disease, treatment, follow up, vaccine

    2-4 weeks

Interventions

QuestionnaireOTHER

Questionnaire to assess the impact of COVID 19 on psoriasis patients

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Psoriasis patients

You may qualify if:

  • Psoriaisis patients

You may not qualify if:

  • Children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

May 18, 2022

First Posted

May 19, 2022

Study Start

May 20, 2022

Primary Completion

June 10, 2022

Study Completion

June 10, 2022

Last Updated

May 19, 2022

Record last verified: 2022-05